Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,875,805
-
Share change
-
+824,123
-
Total reported value
-
$1,221,862,863
-
Put/Call ratio
-
24%
-
Price per share
-
$31.43
-
Number of holders
-
96
-
Value change
-
+$9,654,737
-
Number of buys
-
63
-
Number of sells
-
43
Institutional Holders of CONSTELLATION PHARMCETICLS I - COM (CNST) as of Q1 2020
As of 31 Mar 2020,
CONSTELLATION PHARMCETICLS I - COM (CNST) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,875,805 shares.
The largest 10 holders included
Svennilson Peter, VR Adviser, LLC, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, GREAT POINT PARTNERS LLC, TRV GP, LLC, Point72 Asset Management, L.P., and REGENTS OF THE UNIVERSITY OF CALIFORNIA.
This page lists
96
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.